Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Shares Outstanding (2017 - 2026)

Dyadic International (DYAI) posted Shares Outstanding (Entity) of $36.4 million for Q1 2026, up 11.57% sequentially from $32.6 million in Q4 2025, and up 21.79% YoY from $29.9 million in Q1 2025.

Dyadic International (DYAI) Shares Outstanding (2017 - 2026) Analysis & Trends

Dyadic International has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $36.4 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 21.79% year-over-year to $36.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.4 million (up 21.79% YoY) and the FY2025 annual result came in at $32.6 million, up 11.28% from the prior year.
  • Shares Outstanding (Entity) rose to $36.4 million in Q1 2026 per DYAI's latest filing, from $32.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $36.4 million in Q1 2026 and troughed at $28.3 million in Q1 2022.
  • A 5-year average of $29.9 million and a median of $28.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) increased 0.23% in 2024, then advanced 21.79% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $28.4 million in 2022, then increased by 1.53% to $28.8 million in 2023, then gained by 1.8% to $29.3 million in 2024, then advanced by 11.28% to $32.6 million in 2025, then grew by 11.57% to $36.4 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $36.4 million, $32.6 million, and $34.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Dyadic International 19.98 Mn 19.98 Mn - 28.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.40 Mn
Dec 31, 2025 32.62 Mn
Sep 30, 2025 34.51 Mn
Jun 30, 2025 30.10 Mn
Mar 31, 2025 29.89 Mn
Dec 31, 2024 29.32 Mn
Sep 30, 2024 29.50 Mn
Jun 30, 2024 29.29 Mn
Mar 31, 2024 28.83 Mn
Dec 31, 2023 28.80 Mn
Sep 30, 2023 28.81 Mn
Jun 30, 2023 28.81 Mn
Mar 31, 2023 28.76 Mn
Dec 31, 2022 28.36 Mn
Sep 30, 2022 28.39 Mn
Jun 30, 2022 28.26 Mn
Mar 31, 2022 28.25 Mn
Dec 31, 2021 27.84 Mn
Sep 30, 2021 28.08 Mn
Jun 30, 2021 27.65 Mn